Clinical Trials Directory

Trials / Completed

CompletedNCT05860127

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
133 (actual)
Sponsor
University of Massachusetts, Amherst · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cognitive Stimulation Therapy (CST) is an evidence-based non-pharmacological group therapy shown to benefit people with mild to moderate dementia. Despite increasing availability of CST worldwide, access remains limited in the United States. This pilot pragmatic trial will embed CST referral into the standard care protocol of health care settings that serve people living with dementia in the state of Connecticut, and evaluate online delivery of CST known as virtual CST (V-CST), and assess the acceptability of V-CST to people living with dementia. The study design is a two-armed randomized embedded pragmatic clinical trial (ePCT). The trial aims to determine if cognitive decline is experienced less commonly among V-CST participants than control group members based on three widely used measures of cognition, the Montreal Cognitive Assessment (MoCA), St. Louis University Memory Screen (SLUMS), and Mini Mental State Exam (MMSE). The study population will be persons with mild to moderate dementia identified by clinicians in standard care. From this population, subject participants will be randomized to intervention and control groups. Patients randomly assigned to the intervention group will be referred by their clinical providers to participate in V-CST, and those who accept the referral will participate in the intervention.

Conditions

Interventions

TypeNameDescription
BEHAVIORALReferral for Cognitive Stimulation TherapyPhysician will review participant eligibility for CST treatment and offer referral based on clinical judgement
OTHERNo change to Standard of CareParticipants will not receive referral from a physician. They will continue with standard of care at their site.

Timeline

Start date
2023-04-10
Primary completion
2025-06-12
Completion
2025-06-12
First posted
2023-05-16
Last updated
2026-03-23
Results posted
2026-03-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05860127. Inclusion in this directory is not an endorsement.